Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Trifecta Research Study

NCT: NCT07717866 · ACTIVE_NOT_RECRUITING

NCT IDNCT07717866
StatusACTIVE_NOT_RECRUITING
Start Date2022-08-01
Completion2026-11
SponsorAxial Therapeutic Research (INDUSTRY)
First posted
Last updated

Brief Summary

This observational study evaluates the impact of Ibogaine-Magnesium (IM), 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT), Magnetic e-Resonance Therapy (MeRT), and Physiological Supplementation (PS) on posttraumatic stress disorder (PTSD) and traumatic brain injury-related cognitive symptoms among Special Operations Forces (SOF) combat veterans.

Frequently Asked Questions

What is Trifecta Research Study?

Trifecta Research Study is a clinical trial registered under NCT07717866. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT07717866?

The current status of NCT07717866 (Trifecta Research Study) is: ACTIVE_NOT_RECRUITING.

When did Trifecta Research Study start?

Trifecta Research Study started on 2022-08-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑